KIORA PHARMACEUTICALS
Live / Allowed — Published for opposition (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99358705
- Mark type
- Stylized text
- Filed
- 26 Aug 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- David M. Perry
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, substances, active principles in the nature of therapeutic agents in the form of liquids, solutions, suspensions, injectables, eyedrops, tablets, powders, and capsules that provide the active ingredients for a wide variety of pharmaceuticals, and pharmaceutical compounds all for the treatment of inflammation, immune diseases and disorders, nervous system diseases and disorders, and ophthalmic diseases and disorders; ophthalmic preparations; oral medications in the nature of oral pharmaceuticals and therapeutics all for the treatment of ophthalmic diseases and disorders
Owner
- KIORA PHARMACEUTICALS, INC., Encinitas, CA, US
- KIORA PHARMACEUTICALS, INC., Encinitas, CA, US
Prosecution history
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jan 2026 — ASSIGNED TO EXAMINER
- 26 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 26 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Aug 2025 — NEW APPLICATION ENTERED